Amenamevir
- Generic Name
- Amenamevir
- Drug Type
- Small Molecule
- Chemical Formula
- C24H26N4O5S
- CAS Number
- 841301-32-4
- Unique Ingredient Identifier
- 94X46KW4AE
- Background
Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.
Dose-finding Study of ASP2151 in Subjects With Herpes Zoster
- First Posted Date
- 2007-06-18
- Last Posted Date
- 2018-11-23
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 403
- Registration Number
- NCT00487682
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2017-12-07
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 695
- Registration Number
- NCT00486200
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath